These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10555170)

  • 1. Comparison between MRI, microbiology and histology in evaluation of antibiotics in a murine model of thigh infection.
    Marzola P; Nicolato E; Di Modugno E; Cristofori P; Lanzoni A; Ladel CH; Sbarbati A
    MAGMA; 1999 Oct; 9(1-2):21-8. PubMed ID: 10555170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of BO-3482, a novel dithiocarbamate carbapenem, in mice infected with methicillin-resistant Staphylococcus aureus.
    Nagano R; Shibata K; Naito T; Fuse A; Asano K; Hashizume T; Nakagawa S
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2278-81. PubMed ID: 9333062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomembranous tracheobronchitis caused by methicillin-resistant Staphylococcus aureus.
    Yamazaki Y; Hirai K; Honda T
    Scand J Infect Dis; 2002; 34(3):211-3. PubMed ID: 12030399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Revaluation of current antimicrobials. Series 24: imipenem/cilastatin].
    Kohno S; Wada K
    Jpn J Antibiot; 1994 Dec; 47(12):1629-36. PubMed ID: 7877247
    [No Abstract]   [Full Text] [Related]  

  • 5. Repurposing disulfiram for treatment of Staphylococcus aureus infections.
    Thakare R; Shukla M; Kaul G; Dasgupta A; Chopra S
    Int J Antimicrob Agents; 2019 Jun; 53(6):709-715. PubMed ID: 30954635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical effect of the combined therapy of arbekacin and imipenem/cilastatin against methicillin-resistant Staphylococcus aureus].
    Hashimoto A; Ohtsubo T; Tomono K; Kaku M; Koga H; Kohno S; Hara K; Sugiyama H; Taira K; Inoue Y
    Jpn J Antibiot; 1994 Jun; 47(6):804-12. PubMed ID: 8072190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 19F magnetic resonance imaging of perfluorocarbons for the evaluation of response to antibiotic therapy in a Staphylococcus aureus infection model.
    Hertlein T; Sturm V; Jakob P; Ohlsen K
    PLoS One; 2013; 8(5):e64440. PubMed ID: 23724049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureus.
    Chandrasekar PH; Levine DP; Price S; Rybak MJ
    J Antimicrob Chemother; 1988 Apr; 21(4):461-9. PubMed ID: 3378959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of clindamycin, imipenem, oxacillin and vancomycin in the infected granuloma pouch model.
    Brauner E; Gorbach S; Davey P
    J Antimicrob Chemother; 1989 Jun; 23(6):891-8. PubMed ID: 2759932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.
    Sieradzki K; Roberts RB; Haber SW; Tomasz A
    N Engl J Med; 1999 Feb; 340(7):517-23. PubMed ID: 10021472
    [No Abstract]   [Full Text] [Related]  

  • 11. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
    Giacometti A; Cirioni O; Ghiselli R; Dell'Acqua G; Orlando F; D'Amato G; Mocchegiani F; Silvestri C; Del Prete MS; Rocchi M; Balaban N; Saba V; Scalise G
    Peptides; 2005 Feb; 26(2):169-75. PubMed ID: 15629527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of beta-lactam antibiotics in an animal model against methicillin-resistant Staphylococcus aureus.
    Ling JM; Lam AW; Cheng AF; French GL
    J Antimicrob Chemother; 1993 Dec; 32(6):919-20. PubMed ID: 8144442
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chemotherapy of MRSA infections].
    Inamatsu T
    Nihon Naika Gakkai Zasshi; 1992 Oct; 81(10):1662-7. PubMed ID: 1469319
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacodynamic evaluation of the activities of six parenteral vancomycin products available in the United States.
    Louie A; Boyne MT; Patel V; Huntley C; Liu W; Fikes S; Kurhanewicz S; Rodriquez J; Robbins N; Brown D; Baluya D; Drusano GL
    Antimicrob Agents Chemother; 2015 Jan; 59(1):622-32. PubMed ID: 25385113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
    Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Orlando F; Mocchegiani F; Silvestri C; Licci A; Saba V; Scalise G; Balaban N
    J Infect Dis; 2006 Jan; 193(2):180-6. PubMed ID: 16362881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teicoplanin, vancomycin, rifampicin: in-vivo and in-vitro studies with Staphylococcus aureus.
    Carper HT; Sullivan GW; Mandell GL
    J Antimicrob Chemother; 1987 May; 19(5):659-62. PubMed ID: 2956229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo.
    Totsuka K; Shiseki M; Kikuchi K; Matsui Y
    J Antimicrob Chemother; 1999 Oct; 44(4):455-60. PubMed ID: 10588305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of vancomycin and beta-lactam antibiotics on vancomycin-resistant Staphylococcus aureus.
    Haraga I; Nomura S; Nagayama A
    N Engl J Med; 1999 Nov; 341(21):1624. PubMed ID: 10577134
    [No Abstract]   [Full Text] [Related]  

  • 19. Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis.
    Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Orlando F; Mocchegiani F; Silvestri C; Licci A; Łukasiak J; Saba V; Scalise G
    J Infect Dis; 2005 Nov; 192(9):1613-20. PubMed ID: 16206076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of arbekacin, a new aminoglycoside antibiotic, in surgical patients with MRSA infections].
    Ishikawa S; Yura J; Shinagawa N; Mizuno A; Mashita K; Hori K
    Jpn J Antibiot; 1994 Jun; 47(6):820-5. PubMed ID: 8072192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.